Anesthesia Medical ConsltntsAnesthesia Practice Consultants 100 Michigan St NE, Grand Rapids, MI 49503 6163644200 (phone), 6163647347 (fax)
Education:
Medical School University of Iowa Carver College of Medicine Graduated: 1981
Languages:
English
Description:
Dr. Laughlin graduated from the University of Iowa Carver College of Medicine in 1981. He works in Grand Rapids, MI and specializes in Anesthesiology. Dr. Laughlin is affiliated with Butterworth Hospital, Metrohealth Hospital and Spectrum Health Blodgett Campus.
In general, the invention relates to a pharmaceutical dose having (4-Methoxy-phenyl)-methyl-(2-methyl-quinazolin-4-yl)-amine hydrochloride as the active ingredient that upon administration to a subject provides a Cof about 1 ng/mL to about 250 ng/mL. The dose may be used in methods of treating cancer through the administration of (4-Methoxy-phenyl)-methyl-(2-methyl-quinazolin-4-yl)-amine hydrochloride. The composition of the invention is formulated with one or more pharmaceutically acceptable excipients, salts or carriers.
Disclosed is (4-Methoxy-phenyl)-methyl-(2-methyl-quinazolin-4-yl)-amine hydrochloride effective as a cytotoxic agent. (4-Methoxy-phenyl)-methyl-(2-methyl-quinazolin-4-yl)-amine hydrochloride is useful in the treatment of a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs, and in particular to its use in treating melanoma.
MARK LAUGHLIN - Sunnyvale CA, US Mark B. Anderson - Oakland CA, US Adam Willardsen - Salt Lake City UT, US Chris Pleiman - Holladay UT, US
Assignee:
Myriad Pharmaceuticals, Inc. - Salt Lake City UT
International Classification:
A61K 31/517 A61P 35/00
US Classification:
5142664
Abstract:
Disclosed is (4-Methoxy-phenyl)-methyl-(2-methyl-quinazolin-4-yl)-amine hydrochloride effective as a vascular disrupting agent. (4-Methoxy-phenyl)-methyl-(2-methyl-quinazolin-4-yl)-amine hydrochloride is useful in the treatment of a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs, and in particular to its use in treating cancer.
Disclosed is (4-Methoxy-phenyl)-methyl-(2-methyl-quinazolin-4-yl)-amine hydrochloride effective as a cytotoxic agent. (4-Methoxy-phenyl)-methyl-(2-methyl-quinazolin-4-yl)-amine hydrochloride is useful in the treatment of a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs, and in particular to its use in treating brain cancer.
Methods For Treating Vascular Disruption Disorders
Mark Laughlin - Sunnyvale CA, US Thomas L. Thorne - Salt Lake City UT, US
Assignee:
Myriad Pharmaceuticals, Inc. - Salt Lake City UT
International Classification:
A61K 31/517 A61P 7/12
US Classification:
5142661
Abstract:
Disclosed is (4-Methoxy-phenyl)-methyl-(2-methyl-quinazolin-4-yl)-amine hydrochloride effective as a vascular disrupting agent. (4-Methoxy-phenyl)-methyl-(2-methyl-quinazolin-4-yl)-amine hydrochloride is useful in the treatment of a variety of clinical conditions that are responsive to disruption of the vascular system, and in particular to its use in treating vascular macular degeneration.
Marlatt Elementary School Manhattan KS 1990-1997, Susan B. Anthony Middle School Manhattan KS 1994-1998, Flint Hills Christian High School Manhattan KS 1999-2003
Community:
Lesa Jasinski, Ariana Dilts, Jeff Hayne, Christine Surowski
WhileCampylobacteris a fairly common bacteria among puppies and dogs, its unusual to see a large, multistate outbreak of human infections, said Mark Laughlin, a CDC veterinarian, in an email.Most casesare associated with eating raw or undercooked poultry or meat, or from cross-contamination of